Literature DB >> 17401110

Further biochemical characterization of human pancreatic lipase-related protein 2 expressed in yeast cells.

Cécilia Eydoux1, Josiane De Caro, Francine Ferrato, Paul Boullanger, Dominique Lafont, René Laugier, Frédéric Carrière, Alain De Caro.   

Abstract

Recombinant human pancreatic lipase-related protein 2 (rHPLRP2) was produced in the protease A-deficient yeast Pichia pastoris. A major protein with a molecular mass of 50 kDa was purified from the culture medium using SP-Sepharose and Mono Q chromatography. The protein was found to be highly sensitive to the proteolytic cleavage of a peptide bond in the lid domain. The proteolytic cleavage process occurring in the lid affected both the lipase and phospholipase activities of rHPLRP2. The substrate specificity of the nonproteolyzed rHPLRP2 was investigated using pH-stat and monomolecular film techniques and various substrates (glycerides, phospholipids, and galactolipids). All of the enzyme activities were maximum at alkaline pH values and decreased in the pH 5-7 range corresponding to the physiological conditions occurring in the duodenum. rHPLRP2 was found to act preferentially on substrates forming small aggregates in solution (monoglycerides, egg phosphatidylcholine, and galactolipids) rather than on emulsified substrates such as triolein and diolein. The activity of rHPLRP2 on monogalactosyldiglyceride and digalactosyldiglyceride monomolecular films was determined and compared with that of guinea pig pancreatic lipase-related protein 2, which shows a large deletion in the lid domain. The presence of a full-length lid domain in rHPLRP2 makes it possible for enzyme activity to occur at higher surface pressures. The finding that the inhibition of nonproteolyzed rHPLRP2 by tetrahydrolipstatin and diethyl-p-nitrophenyl phosphate does not involve any bile salt requirements suggests that the rHPLRP2 lid adopts an open conformation in aqueous media.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17401110     DOI: 10.1194/jlr.M600486-JLR200

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  16 in total

1.  BSSL and PLRP2: key enzymes for lipid digestion in the newborn examined using the Caco-2 cell line.

Authors:  Eva-Lotta Andersson; Olle Hernell; Lars Bläckberg; Helen Fält; Susanne Lindquist
Journal:  J Lipid Res       Date:  2011-08-24       Impact factor: 5.922

2.  Pancreatic lipase-related protein-2 (PLRP2) can contribute to dietary fat digestion in human newborns.

Authors:  Xunjun Xiao; Amitava Mukherjee; Leah E Ross; Mark E Lowe
Journal:  J Biol Chem       Date:  2011-06-07       Impact factor: 5.157

3.  Kinetic properties of mouse pancreatic lipase-related protein-2 suggest the mouse may not model human fat digestion.

Authors:  Xunjun Xiao; Leah E Ross; Rita A Miller; Mark E Lowe
Journal:  J Lipid Res       Date:  2011-03-07       Impact factor: 5.922

4.  Pharmacology and safety of glycerol phenylbutyrate in healthy adults and adults with cirrhosis.

Authors:  Brendan M McGuire; Igor A Zupanets; Mark E Lowe; Xunjun Xiao; Vasyliy A Syplyviy; Jon Monteleone; Sharron Gargosky; Klara Dickinson; Antonia Martinez; Masoud Mokhtarani; Bruce F Scharschmidt
Journal:  Hepatology       Date:  2010-06       Impact factor: 17.425

5.  Synthesis and kinetic evaluation of cyclophostin and cyclipostins phosphonate analogs as selective and potent inhibitors of microbial lipases.

Authors:  Vanessa Point; Raj K Malla; Sadia Diomande; Benjamin P Martin; Vincent Delorme; Frederic Carriere; Stephane Canaan; Nigam P Rath; Christopher D Spilling; Jean-François Cavalier
Journal:  J Med Chem       Date:  2012-11-07       Impact factor: 7.446

6.  In vitro gastrointestinal lipolysis of four formulations of piroxicam and cinnarizine with the self emulsifying excipients Labrasol and Gelucire 44/14.

Authors:  Sylvie Fernandez; Stéphanie Chevrier; Nicolas Ritter; Bruno Mahler; Frédéric Demarne; Frédéric Carrière; Vincent Jannin
Journal:  Pharm Res       Date:  2009-05-19       Impact factor: 4.200

7.  Pancreatic lipase-related protein 2 (PLRP2) induction by IL-4 in cytotoxic T lymphocytes (CTLs) and reevaluation of the negative effects of its gene ablation on cytotoxicity.

Authors:  Bryce N Alves; Jeff Leong; David L Tamang; Viki Elliott; Jillian Edelnant; Doug Redelman; Cherie A Singer; Andrew R Kuhn; Rita Miller; Mark E Lowe; Dorothy Hudig
Journal:  J Leukoc Biol       Date:  2009-05-18       Impact factor: 4.962

8.  Hydrolysis of tumor cell lipids after CTL-mediated death.

Authors:  Bryce Alves; Jeff Leong; David L Tamang; Viki Elliott; Mark Lowe; Dorothy Hudig
Journal:  Int Immunol       Date:  2009-03-26       Impact factor: 4.823

9.  In vitro digestion of the self-emulsifying lipid excipient Labrasol(®) by gastrointestinal lipases and influence of its colloidal structure on lipolysis rate.

Authors:  Sylvie Fernandez; Vincent Jannin; Stéphanie Chevrier; Yann Chavant; Frédéric Demarne; Frédéric Carrière
Journal:  Pharm Res       Date:  2013-05-02       Impact factor: 4.200

10.  Lipid-dependent cytotoxicity by the lipase PLRP2 and by PLRP2-positive cytotoxic T lymphocytes (CTLs).

Authors:  Bryce N Alves; Kristen Marshall; David L Tamang; Jeffrey Leong; Doug Redelman; Viki Elliott; Mark E Lowe; Dorothy Hudig
Journal:  Cell Biochem Funct       Date:  2009-07       Impact factor: 3.685

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.